SCHEMBL7704469

SCHEMBL7704469

O=C(N[C@@H](Cc1ccccc1)C(=O)CNS(=O)(=O)c1ccccc1)c1ccccc1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 3/20 0.52
CASP1 P29466 1/20 0.50
CAPN1 P07384 1/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46
BCL2L1 Q07817 1/20 0.46
TACR2 P21452 1/20 0.46
MMP2 P08253 5/20 0.45
MMP9 P14780 4/20 0.45
ADAMTS4 O75173 1/20 0.45
MMP1 P03956 1/20 0.44
GAA P10253 1/20 0.44
MMP12 P39900 1/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
KAT6A Q92794 1/20 0.43
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695923 0.90 ITGB1 (0.52) KCNA5CASP1CAPN1BCL2L1TACR2
SCHEMBL7695358 0.87 CHRNB2 (0.47) KCNA5CAPN1CHRNB2CHRNB4CHRNA3
SCHEMBL7428250 0.84 KCNA5 (0.44) KCNA5CASP1CAPN1BCL2L1MMP2
SCHEMBL7701336 0.83 CASP1 (0.49) KCNA5CASP1MMP2MMP9ADAMTS4
SCHEMBL7689922 0.82 CAPN1 (0.57) KCNA5CASP1CAPN1MMP2MMP9
SCHEMBL7698402 0.80 CHRNB2 (0.52) KCNA5CAPN1CHRNB2CHRNB4CHRNA3
SCHEMBL7689953 0.80 CHRNB2 (0.52) CAPN1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7705654 0.79 CAPN1 (0.46) KCNA5CASP1CAPN1MMP9CA2
SCHEMBL7693964 0.78 CAPN1 (0.50) KCNA5CASP1CAPN1
SCHEMBL7701518 0.78 CA2 (0.44) KCNA5CASP1CAPN1KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed